TransMedics (TMDX) Interest Expenses (2018 - 2026)

TransMedics has reported Interest Expenses for 9 years, with the latest figure at $7.2 million in Q2 2026.

• On a quarterly basis, Interest Expenses rose 107.85% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $21.2 million, a 50.37% increase from a year earlier, with the FY2025 full-year figure at $13.8 million, down 4.35% from the prior year.
• Interest Expenses was $7.2 million for Q2 2026 at TransMedics, up from $7.2 million in the prior quarter.
• The five-year high for Interest Expenses was $7.2 million in Q2 2026, with the low at $787000.0 in Q3 2022.
• Average Interest Expenses over 5 years is $3.2 million, with a median of $3.5 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses declined 19.61% in 2022, then soared 356.16% in 2023.
• Over 5 years, Interest Expenses stood at $1.0 million in 2022, then surged by 257.99% to $3.6 million in 2023, then decreased by 0.94% to $3.6 million in 2024, then retreated by 6.08% to $3.4 million in 2025, then soared by 115.41% to $7.2 million in 2026.
• The last three Interest Expenses figures came in at $7.2 million (Q2 2026), $7.2 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.